Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trial.
- DOI
- 10.1038/s41467-026-74711-8
- Published
- 2026 Jun 23
- Container
- Nature communications
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41467-026-74711-8,
title = {Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trial.},
author = {Wang HH and Huff AL and Haldar SD and Berg M and Thoburn C and Heumann TR and Anders RA and Barrett B and Bever KM and Pishvaian MJ and Lee V and Le DT and Christenson ES and Baretti M and Yarchoan M and Laheru D and Thomas A and Durham JN and Nauroth JM and Lu J and Wang H and Jaffee EM and Azad NS and Zaidi N},
year = {2026},
journal = {Nature communications},
doi = {10.1038/s41467-026-74711-8},
url = {https://doi.org/10.1038/s41467-026-74711-8}
}RIS
TY - JOUR TI - Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trial. AU - Wang HH AU - Huff AL AU - Haldar SD AU - Berg M AU - Thoburn C AU - Heumann TR AU - Anders RA AU - Barrett B AU - Bever KM AU - Pishvaian MJ AU - Lee V AU - Le DT AU - Christenson ES AU - Baretti M AU - Yarchoan M AU - Laheru D AU - Thomas A AU - Durham JN AU - Nauroth JM AU - Lu J AU - Wang H AU - Jaffee EM AU - Azad NS AU - Zaidi N PY - 2026 JO - Nature communications DO - 10.1038/s41467-026-74711-8 UR - https://doi.org/10.1038/s41467-026-74711-8 ER -
APA
HH, W., AL, H., SD, H., M, B., C, T., TR, H., RA, A., B, B., KM, B., MJ, P., V, L., DT, L., ES, C., M, B., M, Y., D, L., A, T., JN, D., JM, N., J, L., H, W., EM, J., NS, A., & N, Z. (2026). Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trial.. Nature communications. https://doi.org/10.1038/s41467-026-74711-8
Source records
- pubmed · retrieved 2026-09-26T15:44:03.025Z